Your browser doesn't support javascript.
loading
Neoadjuvant tislelizumab combination chemotherapy for advanced penile cancer: A case report.
Dou, Wei-Chao; Xu, Juan; Liu, Ji-Yan; Li, Xiang.
Affiliation
  • Dou WC; Department of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Xu J; Operating Room, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, People's Republic of China.
  • Liu JY; Department of Medical Oncology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Li X; Department of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China. Electronic address: xiangli.87@163.com.
Asian J Surg ; 45(3): 968-969, 2022 Mar.
Article in En | MEDLINE | ID: mdl-35012857
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Penile Neoplasms / Neoadjuvant Therapy Limits: Humans / Male Language: En Journal: Asian J Surg Year: 2022 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Penile Neoplasms / Neoadjuvant Therapy Limits: Humans / Male Language: En Journal: Asian J Surg Year: 2022 Document type: Article Country of publication: Netherlands